Rosuvastatin restores advanced glycation end product-induced decrease in sirtuin1 (SIRT1) mRNA levels in THP-1 monocytic cells through its anti-oxidative properties

International Journal of Cardiology

Volumn 169, Issue 6, 2013, Pages

  Ishibashi, Yuji ^a   Nakashima, Sae ^a   Matsui, Takanori ^a   Yamagishi, Sho Ichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AGEs; Oxidative stress; Rosuvastatin; SIRT1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; SIRTUIN 1;

ACUTE CORONARY SYNDROME; AGING; ANTIOXIDANT ACTIVITY; CELL DAMAGE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC MICROANGIOPATHY; ENZYME INDUCTION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; LETTER; MONOCYTE CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIOXIDANTS; CATTLE; CELL LINE, TUMOR; FLUOROBENZENES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MONOCYTES; PYRIMIDINES; RNA, MESSENGER; SIRTUIN 1; SULFONAMIDES;

EID: 84887996741     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.034     Document Type: Article

References (18)

1. H. Vlassara, and R. Bucala Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors Diabetes Suppl. 3 1996 S65 S66
2. S. Rahbar Novel inhibitors of glycation and AGE formation Cell Biochem Biophys 48 2007 147 157
3. S. Yamagishi Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes Exp Gerontol 46 2011 217 224
4. S. Yamagishi B Role of advanced glycation end products (AGEs) in osteoporosis in diabetes Curr Drug Targets 12 2011 2096 2102
5. Y. Ishibashi, T. Matsui, M. Takeuchi, and S. Yamagishi Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase Horm Metab Res 45 2013 387 390
6. R.D. Semba, J.C. Fink, K. Sun, S. Bandinelli, J.M. Guralnik, and L. Ferrucci Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults Eur J Nutr 48 2009 38 44
7. R.D. Semba, S. Bandinelli, K. Sun, J.M. Guralnik, and L. Ferrucci Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults J Am Geriatr Soc 57 2009 1874 1880
8. R.D. Semba, L. Ferrucci, and K. Sun Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women Aging Clin Exp Res 21 2009 182 190
9. J.W. Hwang, H. Yao, S. Caito, I.K. Sundar, and I. Rahman Redox regulation of SIRT1 in inflammation and cellular senescence Free Radic Biol Med 61C 2013 95 110
10. Y. Wang, C. Xu, Y. Liang, and P.M. Vanhoutte SIRT1 in metabolic syndrome: where to target matters Pharmacol Ther 136 2012 305 318
11. N. Braidy, T. Jayasena, A. Poljak, and P.S. Sachdev Sirtuins in cognitive ageing and Alzheimer's disease Curr Opin Psychiatry 25 2012 226 230
12. Y. Ishibashi, T. Matsui, M. Takeuchi, and S. Yamagishi Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1 Horm Metab Res 43 2011 619 624
13. S. Yamagishi, K. Nakamura, and T. Matsui Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression J Biol Chem 281 2006 20213 20220
14. N. Sasaki, M. Takeuchi, and H. Chowei Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques Neurosci Lett 326 2002 117 120
15. S. Yamagishi, Y. Inagaki, and K. Nakamura Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation J Mol Cell Cardiol 37 2004 497 506
16. J. Uribarri, W. Cai, and M. Ramdas Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1 Diabetes Care 34 2011 1610 1616
17. H. Vlassara, J. Uribarri, and W. Cai Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease Clin J Am Soc Nephrol 7 2012 934 942
18. A. Breitenstein, C.A. Wyss, and R.D. Spescha Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease PLoS One 8 2013 e53106